GET DAILY SIGNALSWhy Is Cerebras Systems (CBRS) Stock Down -7.53% Today?
Key Takeaways
- CBRS shares fell roughly 7.53% to $100.96, extending a slide that has erased more than 40% of the stock's value over the past month.
- The primary catalyst is mounting unease over competitive pressure from NVDA on OpenAI inference workloads, compounded by newly announced securities-law investigations over the weekend.
- Secondary drivers include the approaching expiration of post-IPO insider lockups and a short-seller challenge over the durability of the company's wafer-scale processors.
- The decline broke below the stock's prior 52-week low, pushing shares deeper into negative territory relative to their $185 IPO price.
- Traders are now focused on Cerebras' upcoming third-quarter 2026 earnings report, scheduled for November 12.
- For additional detail on this ticker's Price Targets, Earnings, and Forecast, explore the dedicated pages available for this symbol.
- Interested in data-driven trading signals? Explore Trending AI Robots to see which automated strategies are performing best under current market conditions.
Opening Summary
Cerebras Systems, Inc. (CBRS), the Sunnyvale, California-based developer of wafer-scale AI processors and cloud inference infrastructure, moved sharply lower on Monday, with shares trading down roughly 7.53% at $100.96 compared with the previous session's close of $109.18. The decline marks a fresh leg down for a stock that has been under sustained pressure since its May 2026 initial public offering, as investors weigh intensifying competition, legal scrutiny, and an upcoming wave of newly unlocked insider shares.
Competitive Pressure Over OpenAI Workloads
The most persistent overhang on CBRS has been the risk that its marquee customer, OpenAI, may be routing a growing share of its highest-profile inference work to NVDA-based systems rather than Cerebras hardware. A research note suggesting OpenAI's newest "Ultrafast" tier ran on Nvidia GPUs triggered a sharp repricing in recent weeks, given that OpenAI represents the single largest component of Cerebras' contracted backlog. Although OpenAI's chief executive has publicly described Cerebras as a "close partner," the market has continued to treat customer concentration as a key vulnerability, contributing to today's selling pressure.
Securities-Law Investigations and Legal Overhang
Adding to the bearish sentiment, several shareholder-rights law firms announced over the weekend that they had opened investigations into potential violations of federal securities laws at Cerebras. While such announcements are preliminary and do not constitute formal findings of wrongdoing, they can weigh on sentiment by raising the prospect of prolonged legal and regulatory distraction. The timing of these notices—arriving ahead of the company's next earnings report—has amplified investor caution and contributed to the early-session decline.
Lockup Expiration and Insider Selling Pressure
A technical but meaningful headwind is the staggered expiration of post-IPO lockup restrictions, which is freeing up additional shares for potential sale. Reports indicate the final major tranche of pre-IPO shares is set to unlock in early November. That supply overhang follows disclosures that top executives sold hundreds of millions of dollars worth of stock through pre-arranged trading plans in the months after the offering. The combination of insider sales and newly tradable shares has kept a steady source of supply pressure on the stock, even as the company's fundamental backlog remains substantial.
Short-Seller Challenge and Analyst Caution
Recent skepticism has also centered on product durability, with a short-seller report questioning whether Cerebras' wafer-scale processors may experience premature aging or wear—an allegation that has fueled doubts about long-term commercial viability. Separately, Wall Street has turned more cautious, with at least one firm that helped underwrite the IPO cutting its price target sharply, from roughly $275 to $175, even while retaining a positive rating. These developments have reinforced the perception that near-term valuation remains stretched relative to a business that is still generating significant GAAP losses.
Market Context and Trading Activity
The move in CBRS comes amid broader choppiness across AI-adjacent semiconductor names, which have traded with elevated volatility as investors reassess the pace of AI infrastructure spending and the durability of premium valuations. Cerebras has underperformed its sector, breaking below its prior 52-week low and trading well beneath its $185 offering price, which signals that technical momentum remains firmly negative. The decline below key support levels has the potential to trigger additional programmatic and momentum-driven selling in the near term.
What Comes Next for CBRS
The next major catalyst for CBRS is its third-quarter 2026 earnings report, scheduled for after the market close on November 12. Investors will be watching closely for signs that core revenue growth is re-accelerating, whether margins are stabilizing after management guided that the third quarter would mark a trough, and any update on the composition of its customer base and the $25 billion-plus in remaining performance obligations. Risks include further evidence of customer diversification away from Cerebras hardware, additional insider or post-lockup selling, and any escalation of the legal investigations. On the other side, new large-scale cloud partnerships—such as the recently announced collaboration with ORCL—and progress with AMZN Web Services could help restore confidence if execution remains on track.
Trending AI Robots
Tickeron offers hundreds of AI-powered trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in the curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and the symbols they trade, giving users a way to explore data-driven approaches tailored to different market environments. Discover which automated strategies are currently leading the pack by visiting Trending AI Robots.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
CBRS's RSI Indicator is sitting in oversold zone for 1 day
It is expected that a price bounce should occur soon.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
CBRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CBRS as a result. In 8 of 8 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for CBRS turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 1 similar instances when the indicator turned negative. In 1 of the 1 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
CBRS moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CBRS entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.501) is normal, around the industry mean (5.894). P/E Ratio (-20.699) is within average values for comparable stocks, (16.337). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (63.694) is also within normal values, averaging (46.468).
The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. CBRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry Semiconductors
Advertisement